• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例应用 BioSTAR 装置于先天性心脏病儿科患者的各种适应证。

First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease.

机构信息

Department of Pediatric Cardiology and Intensive Care, Childrens Hospital, University of Rostock, Rembrandtstrasse 16/17, 18057 Rostock, Germany.

出版信息

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):72-7. doi: 10.1002/ccd.22233.

DOI:10.1002/ccd.22233
PMID:19787660
Abstract

BACKGROUND

Interventional closure of atrial septal defects (ASD) and surgical tunnel fenestrations in Fontan patients has become the procedure of choice for many years. Recently, the BioSTAR Occluder, a modification of the Starflex device with a resorbable matrix has become available.

PATIENTS

Ten Biostar devices were implanted in nine children with interatrial septal defects, one within a fontan baffle, eight with secundum atrial septal defects. The age of the patients ranged from 11 months to 17 years, the body weight ranged from 12.9-78 kg.

RESULTS

10 BioSTAR devices were implanted in nine patients. In one patient, two BioSTAR devices were used to occlude multiple defects within the oval fossa. All defects were successfully and uneventfully occluded. Mean procedure time was 56 (range 28-125). Mean fluoroscopy time was 4.8 (range 1.1 to 13.0) min. None of the nine patients showed residual shunts after device implantation. After 30 days no shunt was seen in the control transthoracic echocardiography. No adverse effects like allergic reactions, tachyarrhythmia or thrombembolic events occurred in any of the patients.

CONCLUSION

The BioSTAR closure device is a safe and effective device for the closure of a variety of interatrial shunts in children including multifenestrated interatrial defects and fontan fenestrations, however, possible long term consequences (e.g., fractures, recurrent shunts after scaffold degradation) remain to be studied.

摘要

背景

介入性房间隔缺损(ASD)封堵术和 Fontan 患者的手术隧道开窗术多年来一直是首选治疗方法。最近,BioSTAR 封堵器,一种带有可吸收基质的 Starflex 装置的改良版,已经问世。

患者

10 个 Biostar 装置被植入 9 名患有房间隔缺损的儿童中,一个在 Fontan 隔瓣内,8 个为继发孔型房间隔缺损。患者年龄为 11 个月至 17 岁,体重为 12.9-78kg。

结果

10 个 BioSTAR 装置被植入 9 名患者中。在一名患者中,使用两个 BioSTAR 装置来闭塞卵圆窝内的多个缺陷。所有缺陷均成功且无并发症地闭塞。平均手术时间为 56 分钟(范围 28-125 分钟)。平均透视时间为 4.8 分钟(范围 1.1 至 13.0 分钟)。在装置植入后,9 名患者中均无残余分流。30 天后,在控制经胸超声心动图中未发现分流。在任何患者中均未发生过敏反应、心动过速或血栓栓塞等不良事件。

结论

BioSTAR 封堵器是一种安全有效的封堵儿童多种房间隔分流的装置,包括多窗房间隔缺损和 Fontan 开窗,但可能的长期后果(如支架降解后再次出现分流)仍需进一步研究。

相似文献

1
First experience with the BioSTAR-device for various applications in pediatric patients with congenital heart disease.首例应用 BioSTAR 装置于先天性心脏病儿科患者的各种适应证。
Catheter Cardiovasc Interv. 2010 Jan 1;75(1):72-7. doi: 10.1002/ccd.22233.
2
Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.使用生物可吸收封堵器经皮闭合卵圆孔未闭:单中心经验
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):607-14. doi: 10.1002/ccd.22033.
3
Follow-up results of transcatheter occlusion of atrial septal defects with buttoned device.纽扣式封堵器经导管封堵房间隔缺损的随访结果
Can J Cardiol. 1995 Sep;11(8):695-701.
4
Transcatheter closure of secundum atrial septal defects and fenestrated Fontan using the Amplatzer septal occluder. Initial prospective study.
Arch Cardiol Mex. 2003 Jul-Sep;73(3):185-9.
5
Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.使用Amplatzer房间隔封堵器经导管闭合继发孔型房间隔缺损:台湾某单一医学中心的初步结果
Acta Paediatr Taiwan. 2005 Jan-Feb;46(1):17-23.
6
Device closure of large atrial septal defects requiring devices > or =20 mm in small children weighing <20 kg.对于体重小于20千克的小儿,使用尺寸大于或等于20毫米的封堵器经导管闭合大型房间隔缺损。
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):679-86. doi: 10.1002/ccd.21450.
7
A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects.一种用于维持Fontan开窗和房间隔缺损通畅的新型Amplatzer装置。
Catheter Cardiovasc Interv. 2002 Oct;57(2):246-51. doi: 10.1002/ccd.10308.
8
Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults.新型 Figulla ASD Occluder 经导管封堵成人房间隔缺损的早期单中心临床经验。
Arch Cardiovasc Dis. 2011 Mar;104(3):155-60. doi: 10.1016/j.acvd.2010.12.006. Epub 2011 Mar 25.
9
Shunt reduction with a fenestrated Amplatzer device.使用带孔的 Amplatzer 装置减少分流。
Catheter Cardiovasc Interv. 2010 Oct 1;76(4):564-71. doi: 10.1002/ccd.22556.
10
Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device.使用完全可生物吸收封堵器基质进行介入性房间隔缺损封堵:BioSTAR装置的研发与临床前评估
J Am Coll Cardiol. 2006 Jul 4;48(1):161-9. doi: 10.1016/j.jacc.2006.02.057. Epub 2006 Jun 9.

引用本文的文献

1
Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts.用于心房分流的可生物降解封堵装置的最新进展
Rev Cardiovasc Med. 2024 May 8;25(5):159. doi: 10.31083/j.rcm2505159. eCollection 2024 May.
2
The Prevalence of and Predisposing Factors for Late Atrial Arrhythmias after Transcatheter Closure of Secundum Atrial Septal Defects in Children.儿童继发孔型房间隔缺损经导管封堵术后迟发性房性心律失常的发生率及易感因素
J Clin Med. 2023 May 28;12(11):3717. doi: 10.3390/jcm12113717.
3
Favorable mid-term performance of fully biodegradable implantable device for ventricular septal defect closure.
用于室间隔缺损封堵的完全可生物降解植入装置的中期良好性能。
JTCVS Tech. 2022 Dec 10;17:133-137. doi: 10.1016/j.xjtc.2022.11.010. eCollection 2023 Feb.
4
Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder.完全可生物降解房间隔缺损封堵器的动物实验研究
J Biomed Biotechnol. 2012;2012:735989. doi: 10.1155/2012/735989. Epub 2012 Oct 2.
5
Double BioDisk: a new bioprosthetic device for transcatheter closure of atrial septal defects - a feasibility study in adult sheep.双盘生物瓣:一种用于经导管房间隔缺损封堵的新型生物假体装置 - 成年绵羊的可行性研究。
Radiol Oncol. 2012 Jun;46(2):89-96. doi: 10.2478/v10019-012-0029-8. Epub 2012 May 30.
6
Bioabsorbable atrial septal occluder for percutaneous closure of atrial septal defect in children.用于经皮闭合儿童房间隔缺损的生物可吸收房间隔封堵器。
Tex Heart Inst J. 2012;39(2):184-9.